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ABSTRACT
Background: Dengue fever (DF) is responsible for cyclical and frequent epidemic in different parts of India in its
varieties of presentations. In 1992 large number of children died of Dengue hemorrhagic fever (DHF). Aims and
objective: In this study, we evaluated the demography and clinico-pathological profile in dengue affected infants
and children in 2012 Kolkata epidemic. Materials and methods: Total 233 patients (between 1-18 years, with
either Non structural protein 1 antigen or dengue Immunoglobulin positive) admitted in our hospital. After taking
proper history and physical examination, blood were sent for different hematological and biochemical examinations
on the day of admission and after 24-48 hours of admission. We differentiated the dengue patients into DF and DHF
based on platelet count. Results: Male female ratio and DF to DHF ratio were 1: 0.86 and 1: 3.5 respectively. Mean
age of DF and DHF were 10.31±5.41 years and 12.6±4.51 years respectively. Mean duration of fever in DF and
DHF cases were 5.33±1.13 and 6.08±1.79 days respectively. Headache, backache, nausea/vomiting, rash, anorexia,
loose motions were statistically significant in DF. In spite of significant positive tourniquet test in DHF patients
(76.92%), only 13 patients showed evidence of bleeding. Hematocrit (Hct) values between 30-40 and below 30
were significant in DHF and DF patients respectively. Leucopenia and increased liver enzymes (SGOT and SGPT)
were commonly observed in both DF and DHF patients. Hepatomegaly was observed in 13.72% of DF patients,
whereas, isolated hepatomegaly, ascites, combined hepatomegaly with ascites and evidence of pleural effusion were
observed in 4.94%, 1.64%, 3.29% and 7.14% of DHF patients respectively. Conclusion: In seropositive DHF
patients, fever, headache, backache, loose motions were the predominant symptoms associated with hepatomegaly,
elevated liver enzymes and evidence of plasma leakage.
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INTRODUCTION
Over  several  decades,  Dengue,  an  Arbo virus
infection, is responsible for cyclical and more frequent
epidemic  in  rural  as  well  as  urban  areas  of  India,
showing  a  wide  variety  of presentations from
subclinical or mild self limiting disease to severe form
of disease, like, dengue hemorrhagic fever (DHF) and
dengue shock syndrome (DSS).
1 DHF first crept into
Kolkata in 1963-65, this was followed by the recurrent
occurrence of outbreaks.
2 In the 1992 epidemic, large
number  of  affected  children  died  of DHF/DSS.
Dengue  may  be  manifested  by  its  typical  clinical
features, but its presentation may be variable making
the doctor puzzled. Our present study was to evaluate
the demography  and clinic-pathological  profile  of
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dengue fever in infants and children during the 2012
dengue epidemic in Kolkata.
PATIENTS & METHODOLOGY
Inclusion criteria: In 2012 epidemic, total 233 infants
and children between the ages of 1 to 18 years, were
admitted in our hospital on and from the month of 1
st
August  to  31
st October with  either  Non  structural
protein  1  antigen (NS1, antigen)  positive or  dengue
Immunoglobulin M (IgM) positive.
Exclusion  criteria: Patient suffering  from  any
infection, viral hepatitis during this period.
Ethical clearance: This study was started after getting
approval  from  Ethical Committee and  informed
consent form obtained from the patients’ parties.
Methodology: Thorough  history-taking  and  physical
examination was performed in all these patients. Just
after  admission, 5  ml.  of  blood  was  collected
aseptically from  each  patient.  1  ml  of  clotted  blood
was used for non structural protein 1 (NS1) antigen
and  immunoglobulin  M  (IgM) antibody  by  Mac
ELISA  manufactured  by  Panibo  Diagnostics,
remaining  4ml  of Blood sample  was used for
examination of hematological and biochemical profile
immediately.
Between  the  interval  of  24 and 48  hours  after
admission, 4 ml of blood sample was collected. 2 ml
of  blood  was  kept  in  EDTA  vial  and  was  sent  for
platelet  count  both  by  manual  methods  (light
microscopy  and  Neubauer  chamber) and  Coulter
counter method and hematocrit. Rest 2 ml of clotted
blood was used for biochemical tests (SGPT, SGOT).
Daily  platelet  count  was  advised  for  those  patients
having platelet count less than 100000/cc.
Imaging studies like, Ultrasonography and chest x-ray
were performed to detect Ascites and pleural effusion
respectively. We  differentiated  the  dengue  patients
into Dengue  fever  (DF)  and DHF  based  on  platelet
count. (Since there was no DSS detected among in this
group). These patients were treated with intravenous
fluid,  Paracetamol  according  to  WHO  protocol.
3 No
patient was treated with NSAID. When vital statistics
of these patients came to normal; they were discharged
from hospital.
Statistics: Then, we compared the demographic data,
symptoms, laboratory investigations between DF and
DHF by Open stat and Statcalc statistical Calculators.
P  value of  <0.05 was considered  as statistical
significance.
RESULTS
In our study, all our patients were either NS1 (79%) or
IgM (21%) positive.  Male female ratio was 1: 0.86,
whereas ratio of DF to DHF ratio was 1: 3.5. Male to
female ratio in DF was 1: 1 and in DHF, 1:1.16. Mean
age  of  DF  and  DHF  were  10.31±5.41  years  and
12.6±4.51 years respectively [table 1]. All the patients
were admitted with fever. Mean duration of fever in
DF  and  DHF  cases  were  5.33±1.13  and  6.08±1.79
days  respectively. Common  symptoms  were
Headache  (62.74%, 30.76%),  backache  (58.82%,
30.76%),  nausea/vomiting  (62.74%,  47.25%), rash
(29.41%, 15.93%), anorexia (60.78%, 13.73%), loose
motion (35.29%, 18.68%) in  both  DF  and  DHF
respectively. In spite of significant positive tourniquet
test  in  DHF  patients  (76.92%),  severe  bleeding was
seen  in  only  13  patients. [Table 2]. Most  of  the
patients were anemic. Hematocrit (Hct) between 30-40
was  significant  in  DHF  patients,  whereas, Hct was
observed below  30 in  significant  number  of DF
patients. Leucopenia and raised liver enzymes (SGOT
and SGPT) were commonly observed in both DF and
DHF patients without any statistical difference. But,
the International  normalized  ratio  (INR) was  only
elevated  more  than  1.5  in  DHF  patients [Table  3].
Sonographically, Isolated hepatomagaly observed  in
13.72% and 4.94% DF and DHF patients respectively,
whereas, ascites and ascites associated  with
hepatomagaly were observed in 1.64% and 3.29% of
DHF patients respectively. Again, chest x-ray showed
evidence  of  pleural  effusion in  DHF  patients  only
[Table 4].
Table 1: Demographic distribution
Features DF (51) DHF (182) P value
Mean age yrs 10.31 ±5.41 12.6 ±4.51 0.04*
Male sex 26 98 0.35
Female sex 25 84 0.35
*significant61
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Table 2: Common symptoms
Symptoms DF (51) DHF  (182) % Amongst total (233) P value
Fever (days) 5.33±1.13 6.08±1.79 - 0.0001**
Headache 32 (62.74 %) 56(30.76%) 88 (37.76%) 0.00001***
Backache 30 (58.82%) 56 (30.76%) 86(36.90%) 0.0001**
Nausea/vomiting 32 (62.74%) 86 (47.25%) 136(58.36%) 0.02*
Rash 15 (29.41%) 29 (15.93%) 44 (18.88%) 0.01*
Anorexia 31 (60.78%) 52 (13.73%) 83(35.62%) 0.00001***
Loose motion 18 (35.29%) 34 (18.68%) 52 (22.31%) 0.005**
Retro orbital pain 4 (7.8%) 6 (3.29%) 10 (4.29%) 0.07
Types of bleeding
Positive tourniquet test 0 140 (76.92%) 140 (60.08%)
Epistaxis 0 3 (1.64%) 3(1.28%)
Skin 0 4 (2.19%) 4(1.71%)
Gum 0 3 (1.64%) 3(1.28%)
Hematemesis/melena 0 3 (1.64%) 3 (1.28%)
*-- Significant, **-- Very significant, *** -- Extremely significant
Table 3: Hematological, biochemical distribution:
Parameter DF (51) DHF (182) % amongst total (233) P value
Hematocrit (L/L)
≥40 (37) 2 (3.92%) 4 (2.19%) 6 (2.57%) 2.46
(30-40) 20 (39.21%) 120 (65.93%) 140 (60.08%) 0.0003**
(<30) 29 (56.86%) 58 (31.86%) 37.33 0.0006**
Hemoglobin (gm/dl) 10.5±1.4 10.3±1.1 -
Total leukocyte count
<1000-3000/cc 20 (39.21%) 60 (32.96%) 80 (34.33%) 0.20
>3000-4000/cc 19 ( 37.25%) 80 (43.95%) 99(42.48%) 0.19
>4000/cc 12 (23.52%) 42 (23.07 %) 54(23.17%) 0.47
Platelet count
≤20000/cc (8) 0 8 ( 4.39%) 8(3.43%) -
>20000 – 40000/cc 0 28 (15.38%) 28(12.01%) -
SGOT >3 times normal 15 (29.41%) 66 (36.26%) 81(34.76%) 0.18
SGPT  >100 – 200 IU/L 10 (19.60%) 31 (17.03%) 41(17.59%) 0.33
SGPT >200 – 350 IU/L 5 (9.80%) 18 (9.89%) 23 (9.87%) 0.49
SGPT >350 IU/L 2 (3.92%) 14 (7.69%) 16 (6.86%) 0.17
INR >1.5 (21) 0 21 (11.53%) 21 (9.01%) -
** Very significant, SGOT: Serum aspartate aminotransferase, SGPT: Serum alanine aminotransferase; INR:
International normalized ratio
Table 4: Radiological distribution:
Items DF (51) DHF (182) % Amongst total patients (233)
USG
Ascites 0 3 (1.64%) 1.28
Hepatomegaly 7 (13.72%) 9 (4.94%) 6.86
Ascites & Hepatomegaly 0 6 (3.29%) 2.57
Hepatosplenomegaly 0 0 0
Chest x-ray 0 13 (7.14%) 5.5762
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DISCUSSION
Age  group  affected  by  dengue  fever  as  shown  by
Narayanan et al
4 was 7 to 8 years of age, which was
similar to the study done by Kabra SK et al
5 and Banik
GB  et  al.
6 Though  dengue  fever  is  a  well-known
disease of child-age group, but since 1980’s there is
slight inclination towards higher age group in case of
DHF, as shown in various studies in Latin America
and South-East Asia. Similarly, in our study, the mean
age  was  10.31  and  12.6  years  in  DF  and  DHF
respectively.  Though  according  to  previous  belief,
DHF/DSS is due to either previous infection or passive
transfer of antibody from the mother
7, but in our study,
DHF occurred at higher age group – so it may be due
to antibodies, acquired by the patients at earlier ages.
According to some author, it may be due to virulent
virus rather than pre-infection antibody status.
8
Few  available  hospital  studies  demoed  male-female
distribution in dengue fever. Kabra SK et al
5 showed
girl preponderance as also seen in the study done by
Mittal H et al.
9Three independent studies  in India and
Singapore  showed that males  were  twice  more
common than females.
10  ,  11 Hospital based study in
Delhi showed male to female ratio 2.5:1.
12 Similarly,
in our study, there was slight edging of boys over girls.
In  study  done  by  Mittal  et  al  showed  that  fever
(100%), headache (63%), abdominal pain (71%) and
petechiae  (35.5%)  were  more  common.
9 Fever,
vomiting were most frequent symptoms as shown by
Narayanan M et al.
4 Similar pictures were observed in
our study, but in addition, headache, anorexia was also
frequently found.
In our study, 76.92% DHF patients showed positive
tourniquet test, which was much higher than that was
observed in the study of Kabra et al.
5 It may be due to
thrombocytopenia  and  capillary  fragility, either  or
both. Low proportion of positivity in tourniquet test in
Indian population may be due to darker skin color or
dengue strain difference in Indian subcontinent.
13,  14.
The  tourniquet  test  will  never  correlate  with  overt
bleeding  manifestation  as shown  by  Wali  et  al.
15 It
may  be  due  to  difference  in  pathogenesis,  like,
vascular permeability and/or capillary fragility.
Since in our study, only 13 patients showed evidence
of bleeding, amongst them, evidence of epistaxis, gum
bleeding and hematemesis were observed in 1.64% of
DHF  patients,  which  was  very  low  as  compared  to
other  studies
5. According  to  WHO’s protocol  for
management  of  DHF,  1-2  hourly  documentation  of
Hematocrit (Hct) value is very essential for monitoring
intravenous  fluid  therapy.  But,  if  pretreatment  Hct
value is not known, it is very difficult to demonstrate
the  percentage  of  hemoconcentration in  DHF.
Hemoconcentration  is  very  important  factor  that
correlates platelet count with bleeding manifestations.
This was shown in different studies.
16, 17. In our study,
Hct >40 was observed in 3.92% of DF and 2.19% of
DHF patients, whereas, Hct >30-40 was observed in
65.93% of DHF patients. So according to our study, it
may  not  be  a  good  indicator  of  monitoring  fluid
therapy in infants and children in presence of moderate
anemia  which  was  near  10  gm%  in  our  study
population.
In our study, leucopenia (<5000/cc) was observed in
76.81% of patients, whereas, Ratageri et al
18 showed
21%  of  patients  suffered  from  leucopenia  and
Benerjee
19 et  al  demonstrated  no  evidence  of
leucopenia  in their studies. So, leucopenia may be an
indicator  of  virulent  dengue  strain  in  our  epidemic.
Our  study  showed  182  (78.11%)  children  suffered
from thrombocytopenia, amongst them, 36 (19.77%)
had  platelet  count  <40000/cc.  Similarly,  82%  and
96%rombocytopenic  patients  were  described  in  the
studies  of  Ratageri  et  al
18 and  Banerjee  et  al
19
respectively. This  thrombocytopenia  may  be  due  to
decreased production in bone marrow, temporary bone
marrow  suppression
20,  virus-antibody  complex
mediated immune destruction
21 of platelet or increased
consumption of  platelet  induced  by  secondary
infection  associated  with  release  of  high  level  of
platelet activating factors or increased adhesiveness of
platelet to the vascular endothelial cells.
22
In DHF, there may be evidence of plasma leakage as
evidenced by ascites and pleural effusion. In our study,
13  (7.14%)  patients  showed  evidence  of  pleural
effusion in the chest x-ray, 3 (1.64%) patients suffered
from isolated ascites and 6 patients (3.29%) suffered
from  ascites  associated  with  hepatomegaly.  On  the
contrary,  70%  and  54%  of  children  demonstrated
pleural effusion and ascites respectively in the study of
Ratageri  et  al.
18 According  to  some  observations,
massive  T-cell  activation  producing  cytokines
(interferon γ, interleukin 2 and TNF α) and infected
cell  lysis  by  CD  4+  and  CD8+  dengue  specific
lymphocytes  are  mainly  responsible  for  plasma63
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leakage.  Interaction  between infected  cells and
immune cells induces release of cytokines directly by
macrophages and monocytes.
One important laboratory finding is elevation of liver
enzymes, which was reported in various studies.
23-.25.
Similarly, in our study, the rise in SGPT >100 U/L
was observed in 34.32% of patients.
Evidence  of  vomiting,  hepatomegaly  and  elevated
liver  enzymes  may  be  a  clue  to  the  diagnosis  of
dengue in the background of the epidemic.
CONCLUSION
Dengue fever is more prevalent in Kolkata. Mean age
of DF and DHF patients were 10.31 and 12.6 years
respectively.  Male  to  female  ratio  was  1.13:1. In
seropositive DHF patients, fever, headache, backache,
loose  motions  were  the  predominant  symptoms
associated with hepatomegaly, elevated liver enzymes
and evidence of plasma leakage. Leucopenia may be
due to a virulent strain of dengue virus.
Key-massage: Evidence of fever, vomiting, backache
with  or  without  bleeding  associated  with
hepatomegaly,  elevated  liver  enzymes  and
thrombocytopenia may be a clue to the diagnosis of
dengue hemorrhagic fever. Due to the high prevalence
of anemia, rise in Hematocrit is not at all helpful to the
diagnosis of DHF.
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